Cholinergic urticaria: pathogenesis‐based categorization and its treatment options

@article{Nakamizo2012CholinergicUP,
  title={Cholinergic urticaria: pathogenesis‐based categorization and its treatment options},
  author={Satoshi Nakamizo and Gyohei Egawa and Yoshiki Miyachi and Kenji Kabashima},
  journal={Journal of the European Academy of Dermatology and Venereology},
  year={2012},
  volume={26}
}
Background  Cholinergic urticaria (CU) has well‐described characteristic clinical presentations, yet the precise pathological mechanism remains incompletely understood. A variety of pathogeneses has been proposed, which suggests that there exists several clinical subtypes. 
Cholinergic urticaria: More than a simple inducible urticaria
TLDR
The spectrum of symptoms and signs of ChU in Korean patients are evaluated in order to evaluate the pathomechanism and various aspects of its clinical manifestations. Expand
Atopic predisposition in cholinergic urticaria patients and its implications
TLDR
A higher frequency of atopy among CholU patients has been reported, but the significance of this observation is unclear. Expand
Cholinergic urticaria patients of different age groups have distinct features
TLDR
Cholinergic urticaria (CholU) is a common skin disease characterized by the development of pinpoint‐sized weals and severe itch upon physical exercise and has the highest prevalence among young adults. Expand
Cholinergic Urticaria Associated with Acquired Generalized Hypohidrosis: Two Case Reports and Review of the Literature
TLDR
This work reports two cases of this extremely rare association of cholinergic urticaria and acquired generalized hypohidrosis, and briefly review current knowledge with regard to classification, ethiopathogenesis and therapeutic options. Expand
Management and treatment of chronic urticaria (CU)
TLDR
The different therapeutic options for patients with chronic spontaneous urticaria are reviewed and management of special populations or special circumstances related to CU is discussed. Expand
Pathogenesis of cholinergic urticaria in relation to sweating.
TLDR
This work attempts to classify CU and address the underlying mechanisms of CU based on the published data and the findings, and divides patients into three subtypes: CU with sweat hypersensitivity; CU with acquired anhidrosis and/or hypohidrosis; and idiopathic CU. Expand
Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management
TLDR
Because cholinergic urticaria is not a homogeneous disease, its subtype classification is essential for selection of the most suitable therapeutic method. Expand
How to Approach Chronic Inducible Urticaria.
TLDR
The clinical features, the diagnostic workup including provocation and threshold testing, and available treatment options are discussed, with an emphasis on symptomatic dermographism, cold urticaria, cholinergic uricaria, and delayed pressure Urticaria. Expand
Danazol and Ketotifen in a Refractory Cholinergic Urticaria: Case Report
Cholinergic urticaria (ChU) is a type of induced urticaria characterized by small and pruritic wheals which are triggered by specific stimuli such as physical exercise thus significantly impairingExpand
The definition, diagnostic testing, and management of chronic inducible urticarias – The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision
TLDR
These recommendations for the definition, diagnosis and management of chronic inducible urticaria (CIndU) extend, revise and update the previous consensus report on physical urticarias and cholinergic uricaria (Allergy, 2009), and acknowledge the latest changes in understanding of CIndU. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Treatment of chronic urticaria with a beta2‐adrenergic stimulant
TLDR
Patients with chronic urticaria resistant to conventional therapy were treated orally with terbutaline, a specific β2 stimulant, and the efficacy was independent of the IgE levels; it seemed greater in idiopathic cases than in cholinergic or pressure induced urticarial. Expand
Successful treatment of disabling cholinergic urticaria.
TLDR
A 22-year-old African American U.S. sailor presented with an intermittent pruritic eruption precipitated by mild activity for the last 2 years, and was diagnosed with cholinergic urticaria, successfully controlled with a combination of cetirizine, montelukast, and propanolol. Expand
A case of cholinergic urticaria associated with acquired generalized hypohidrosis and reduced acetylcholine receptors: cause and effect?
TLDR
It is hypothesized that CU with AGH might be caused by autoimmunity to the sweat glands or to the muscarinic acetylcholine receptors (mAChRs) on these glands, and immunohistochemical analysis of mAChR expression was performed, and it was found that the patient had uncommonly low mA cholinergic urticaria expression in the inner cells of the sweat gland. Expand
Severe refractory cholinergic urticaria treated with danazol.
TLDR
D danazol is a viable alternative for the treatment of cholinergic urticaria in cases that fail to respond to traditional forms of treatment and should be reserved for more severe and refractory cases. Expand
Cholinergic Urticaria, a New Pathogenic Concept: Hypohidrosis due to Interference with the Delivery of Sweat to the Skin Surface
TLDR
It is thought that such a hypohidrosis due to occlusion of superficial sweat ducts may also play a role in many other patients with CU of unknown etiology that becomes exacerbated in winter when sweating is not a frequent event. Expand
New concepts of hive formation in cholinergic urticaria
TLDR
Two subtypes of cholinergic urticaria are proposed: a sweat-hypersensitivity type with strong hypersensitivity to autologous sweat, nonfollicular hives, development of satellite wheals, and lack of positive ASST; and a follicular type with follicular h Hive and positive AS ST, but no hypersensitivity of autologously sweat or satellite wheal. Expand
[Cholinergic urticaria successfully treated by immunotherapy with partially purified sweat antigen].
TLDR
Both pruritus and wheals improved gradually, and the reactivity of his peripheral blood leukocytes against sweat antigen decreased as immunotherapy was proceeded, indicating that he has been IgE-sensitized to an antigen(s) in human sweat. Expand
Cholinergic urticaria successfully treated with scopolamine butylbromide
TLDR
Marked pruritus and many small eruptions were induced by exercise and warmth, and these symptoms were resistant to ordinary H1 receptor antagonists such as cetirizine hydrochloride, d -chlorpheniramine maleate, hydroxyzine, mequitazine, clemastine fumarate, or the H2 receptor antagonist famotidine. Expand
Successful treatment of cholinergic urticaria with anti‐immunoglobulin E therapy
TLDR
The study revealed that public knowledge about bee/wasp allergy, and behaviour for searching medical care, even among patients who had overcome life-threatening events, is not sufficient in eastern Turkey. Expand
CHOLINERGIC URTICARIA: ACETYLCHOLINE-RECEPTOR-DEPENDENT IMMEDIATE-TYPE HYPERSENSITIVITY REACTION TO COPPER
TLDR
A patient with cholinergic urticaria syndrome was found to have an unusually large number of muscarinic Cholinergic receptors in the urticarial sites, which may account for her heightened sensitivity to acetylcholine discharge following exercise, heat, and emotion. Expand
...
1
2
3
...